Phase II Trial of Pasireotide to Prevent GI Toxicity and Acute Gvhd in Allogeneic HSCT
Author(s) -
Sendhilnathan Ramalingam,
Sharareh SiamakpourReihani,
Lauren Bohan,
Yi Ren,
Alexander B. Sibley,
Andrew B. Nixon,
Jing Lyu,
Jichun Xie,
Taewoong Choi,
Cristina Gasparetto,
Mitchell E. Horwitz,
Gwynn D. Long,
Richard D. Lopez,
David A. Rizzieri,
Stefanie Sarantopoulos,
Nelson J. Chao,
Anthony D. Sung
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.120
Subject(s) - medicine , pasireotide , toxicity , gastroenterology , hematopoietic stem cell transplantation , graft versus host disease , regimen , treosulfan , acute toxicity , surgery , transplantation , busulfan , growth hormone , hormone , acromegaly
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom